Advertisement
Rapid Communication| Volume 26, ISSUE 6, P637-639, October 1989

Treatment of cocaine abuse with buprenorphine

  • Thomas R Kosten
    Correspondence
    Address reprint requests to Dr. Thomas Kosten, Substance Abuse Treatment Unit, 27 Sylvan Avenue, New Haven, CT 06519.
    Affiliations
    From the Substance Abuse Treatment Unit, Department of Psychiatry, Yale University School of Medicine, New Haven ConnecticutU.S.A.
    Search for articles by this author
  • Herbert D Kleber
    Affiliations
    From the Substance Abuse Treatment Unit, Department of Psychiatry, Yale University School of Medicine, New Haven ConnecticutU.S.A.
    Search for articles by this author
  • Charles Morgan
    Affiliations
    From the Substance Abuse Treatment Unit, Department of Psychiatry, Yale University School of Medicine, New Haven ConnecticutU.S.A.
    Search for articles by this author
DOI:https://doi.org/10.1016/0006-3223(89)90090-5
Treatment of cocaine abuse with buprenorphine
Previous ArticleThe effect of oral dextroamphetamine on plasma cortisol in major depressive disorder
Next ArticleA study of the complement system in psychiatric patients
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Chambers CD
        • Taylor WJR
        • Moffett AD
        The incidence of cocaine abuse among methadone maintenance patients.
        Int J Addict. 1972; 7: 427-441
      2. Cooper JR Altman F Brown BS Czechowicz D Research on the Treatment of Narcotic Addiction. National Institute on Drug Abuse, Rockville, Md1983
        • Dackis CA
        • Gold MS
        Bromocriptine as treatment of cocaine abuse (letter).
        Lancet. 1985; 1: 1151-1152
        • Kaul B
        • Davidow B
        Drug abuse patterns of patients on methadone maintenance treatment in New York City.
        Am J Drug Alcohol Abuse. 1981; 8: 17-25
        • Kosten TR
        Buprenorphine detoxification from opioid dependence: A pilot study.
        Life Sci. 1988; 42: 635-641
        • Kosten TR
        Pharmacotherapeutic interventions for cocaine abuse: Matching patients to treatments.
        J Nerv Mental Dis. 1989; (in press).
        • Kosten TR
        • Rounsaville BJ
        • Kleber HD
        A 2.5 year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?.
        Arch Gen Psychiatry. 1987; 44: 281-284
        • Kosten TR
        • Rounsaville BJ
        • Kleber HD
        Antecedents and consequences of cocaine abuse among opioid addicts.
        J Nerv Mental Dis. 1988; 176: 176-181
        • Kosten TR
        • Schumann B
        • Wright DR
        • Carney MK
        • Gawin FH
        A pilot study using desipramine for cocaine abusing methadone maintenance patients.
        J Clin Psychiatry. 1987; 48: 442-444
        • Kosten TR
        • Schumann B
        • Wright DR
        Bromocriptine treatment of cocaine abuse in methadone maintained patients (letter).
        Am J Psychiatry. 1988; 145: 381-382
        • Lewis JW
        Buprenorphine.
        Drug Alcohol Depend. 1985; 14: 363-372
        • Morgan CJ
        • Kosten TR
        • Gawin FH
        • Kleber HD
        A pilot trial of amantadine for cocaine abuse.
        in: Harris LS Proc Committee on Problems of Drug Dependence, 1987 National Institute on Drug Abuse, Rockville, Md1988: 81-85

      Article info

      Publication history

      Received in revised form: March 2, 1989
      Received: December 15, 1988

      Footnotes

      ☆Supported by the National Institute on Drug Abuse grants #P50-DA04050, R01-DA04505, and Research Scientist Development Award K02-DA00112 to TRK.

      Identification

      DOI: https://doi.org/10.1016/0006-3223(89)90090-5

      Copyright

      © 1989 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX